Andrew W Stacey, MD MS
Contact information
LOCATION
LINKEDIN
https://www.linkedin.com/in/andrew-stacey-60462b5/
SPECIALTY
Ophthalmic Oncologist
Education and Fellowships
FELLOWSHIP
Moorfields Eye Hospital
RESIDENCY
University of Michigan
MEDICAL SCHOOL
The Ohio State University
Current Positions
Assistant Professor
Ocular Oncology
Department of Ophthalmology
University of Washington
LOCATION
- Department of Ophthalmology, University of Washington
Box 359608 325 Ninth Ave, Seattle, WA 98104
Map and directions »
https://www.linkedin.com/in/andrew-stacey-60462b5/
SPECIALTY
Ophthalmic Oncologist
Education and Fellowships
FELLOWSHIP
Moorfields Eye Hospital
RESIDENCY
University of Michigan
MEDICAL SCHOOL
The Ohio State University
Current Positions
Assistant Professor
Ocular Oncology
Department of Ophthalmology
University of Washington
Biography
ACADEMIC APPOINTMENTS:
Assistant Professor, Ocular Oncology
Department of Ophthalmology
University of Washington
Seattle, Washington
September 2016 - Present
MEDICAL TRAINING:
Ocular Oncology Fellowship, August 2015 – August 2016
Moorfields Eye Hospital and St. Bartholomew Hospital
London, England, United Kingdom
Ophthalmology Residency, July 2012 – June 2015
The University of Michigan Kellogg Eye Center
Ann Arbor, Michigan
Transitional Year Internship, July 2011 – June 2012
Riverside Methodist Hospital, OhioHealth
Columbus, Ohio
EDUCATION:
Doctor of Medicine, 2007- 2011.
The Ohio State University. Columbus, OH.
Master of Science, Statistics. 2005 – 2007
Brigham Young University. Provo, UT.
Thesis: “An Adaptive Bayesian Approach to Bernoulli Response Clinical Trials”
Bachelor of Science, Biostatistics. 2000-2005
Brigham Young University. Provo, UT.
SOCIETY MEMBERSHIP:
2012-Present American Academy of Ophthalmology
2012-Present Association for Research in Vision and Ophthalmology
2013-Present International Society of Ocular Oncology
2016-Present Washington Academy of Eye Physicians and Surgeons
PEER REVEIWED PUBLICATIONS:
1. Fabian ID, Stacey AW, Sagoo MS, Reddy MA. "Primary Enucleation for Group D Retinoblastoma in the Era of Systemic and Targeted Chemotherapy: The Price of Retaining an Eye." British Journal of Ophthalmology. In Press
2. Fabian ID, Thaung C, AlHarby L, Sisley K, Mudhar HS, Doherty RE, Stacey AW, Arora AK, Cohen VML, Sagoo MS. “Late Solitary Extraocular Recurrence from Previously Resected Iris Melanoma.” American Journal of Ophthalmology. In Press
3. Fabian ID, Naeem Z, Stacey AW, Chowdhery T, Duncan C, Reddy MA, Sagoo MS. “Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes.” American Journal of Ophthalmology. 179. July 2017, pp. 137-144
4. Stacey AW, Lavric A, Thaung C, Siddeq S, Sagoo MS. “Solitary Iris Plasmacytoma With Anterior Chamber Crystalline Deposits.” Cornea. 36(7). July 2017, pp: 875-877.
5. Fabian ID, Stacey AW, Chowdhury T, Duncan C, Karaa EK, Scheimberg I, Reddy MA Sagoo MS. "High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes." Ophthalmology. 124(6). June 2017, pp. 851-858
6. Fabian ID, Johnson KP, Stacey AW, Sagoo MS, Reddy MA. “Focal laser treatment in addition to chemotherapy for retinoblastoma.” Cochrane Database Systemic Reviews. June 2017.
7. Fabian ID, Stacey AW, Papastefanou V, Al Harby L, Arora AK, Sagoo MS, Cohen VML "Primary Photodynamic Therapy with Verteporfin for Small Pigmented Posterior Pole Choroidal Melanoma" Eye. 31(4). April 2017, pp. 519-528.
8. Fabian ID, Stacey AW, Johnson KC, Onadim Z, Chowdhury T, Duncan C, Reddy MA Sagoo MS. "Primary Intravenous Chemotherapy for Group D Retinoblastoma: A 13-Year Retrospective Analysis." British Journal of Ophthalmology. 101(1). January 2017, pp. 82-88.
9. Kondapalli SS, Czyz CM, Stacey AW, Cahill KV, Foster JA. "Use of Kaolin-impregnated Gauze for Improvement of Intraoperative Hemostasis and Postoperative Wound Healing in Blepharoplasty." Journal of Clinical Aesthetic Dermatology. 9(6). June 2016, pp. 51-55.
10. Kahana A, Gemmete JJ, Stacey AW. “Author Response: Periorbital Sclerotherapy Caution." Ophthalmic Plastic and Reconstructive Surgery. 32 (3). May-June 2016. 238-239
11. Stacey AW, Demirci H “Serial Intravitreal Bevacizumab Injections Slow the Progression of Radiation Maculopathy Following Iodine-125 Plaque Radiotherapy". The Open Ophthalmology Journal. 10. March 2016. 103-110.
12. Stacey AW, Borri M, De Francesco S, Antenore AS, Meniacacci F, Hadjistiliano T. “A Case of Anterior Chamber Cholesterolosis Due To Coats' Disease and A Review of Reported Cases.” The Open Ophthalmology Journal. 10. February 2016. 27-32
13. Wu CY, Stacey AW, Kahana A. “Simultaneous Versus Staged Balanced Decompression for Thyroid-Related Compressive Optice Neuropathy." Ophthalmic Plastic and Reconstructive Surgery. 32(6). Nov/Dec 2016. Pp. 462-467
14. Czyz CN, Bacon T, Stacey AW, Cahill EN, Costin BR. Karanfilov BI, Cahill KV. “Nasolacrimal system aeration on computed tomographic imaging: sex and age variation.” Ophthalmic Plastic and Reconstructive Surgery. 32(1). Jan-Feb 2016. 11-16.
15. Stacey AW, Gemmete JJ, Kahana A. “Management of Orbital and Periocular Vascular Anomalies: A Review.” Ophthalmic Plastic and Reconstructive Surgery. 31 (6). Nov-Dec 2015. pp: 427-436
16. Stacey AW, Sparagna C, Borri M, Rizzo S, Hadjistiliano T. “A 6-year-old boy with Cornealia de Lange Syndrome and Coats' Disease: case report and review of the literature.” Journal of the American Association for Pediatric Ophthalmology and Strabismus. 19 (5). October 2015. pp: 474-478.
17. Breker DA, Stacey AW, Srinivasan A, Bursztyn L, Trobe JD, Johnson MW. “Vision Loss Caused by Retinal and Lateral Geniculate Body Infarction in H1N1 Influenza.” Journal of Neuroophthalmology. 35 (3). September 2015. pp: 265-269.
18. Stacey AW, Czyz CN. “Author Response: Risk of Ocular Blood Splatter During Oculofacial Plastic Surgery.” Investigative Ophthalmology and Visual Science (IOVS). 31 (3). May-June 2015. pp: 248
19. Stacey AW, Czyz CN, Foster JA. “Risk of Ocular Blood Splatter During Oculofacial Plastic Surgery.” Ophthalmic Plastic and Reconstructive Surgery. 31(3). May-June 2015. pp: 182-186
20. Stacey AW, Sozener CB, Besirli CG. “Hypertensive Emergency Presenting as Blurry Vision in a Patient with Hypertensive Chorioretinopathy.” International Journal of Emergency Medicine. 8 (13). April 23, 2015.
21. Czyz CN, Bacon T, Stacey AW, Cahill EN, Costin BR. Karanfilov BI, Cahill KV. “Nasolacrimal system aeration on computed tomographic imaging: effects of patient positioning and scan orientation.” Clinical Ophthalmology. 11(9). March 2015. pp: 469-73.
22. Stacey AW, Czyz CN. “Author Response: An Analysis of the Use of Multiple Comparison Corrections in Ophthalmology Research.” Investigative Ophthalmology and Visual Science (IOVS). 53(9), 2012. pp:5955
23. Stacey AW, Pouly S, Czyz CN. “An Analysis of the Use of Multiple Comparison Corrections in Ophthalmology Research.” Investigative Ophthalmology and Visual Science (IOVS). 53(4), 2012. pp:1830-4
24. Hill RH, Shiels WE, Foster JA, Czyz CN, Stacey A, Everman DR, Cahill KV. “Percutaneous Drainage and Ablation as First Line Therapy for Macrocystic and Microcystic Orbital Lumphatic Malformations.” Ophthalmic Plastic and Reconstructive Surgery. 28(2), 2012. pp:119-25
25. Dolman PJ, Cahill K, Czyz CN, Douglas RS, Elner VM, Feldon S, Kazim M, Lucarelli M, Sivak-Collcott J, Stacey AW, Strianese D, Uddin J. “Reliability of estimating ductions in thyroid eye disease: an international thyroid eye disease society multicenter study.” Ophthalmology. 119(2), 2012. pp:382-9
26. Czyz CN, Kalwerisky K, Stacey AW, Foster JA, Hill RH, Everman KR, Cahill KV, DeMartelaere S. “Initial treatment of ocular exposure and associated complications in severe periorbital thermal injuries.” Journal of Trauma. 71(5), 2011. pp: 1455-9
27. Stacey A, Sheffield N, Crandall KA, “Calculating expected DNA remnants from ancient founding events in human population genetics.” BMC Genetics. 9:66, 2008.
28. Hitomi M, Yang K, Stacey AW, Stacey DW, “Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle progression.” Molecular and Cellular Biology 28(17), 2008
29. Sa G, Hitomi M, Harwalkar J, Stacey AW, GC GC, Stacey DW, “Ras Is Active Throughout the Cell Cycle but Is Able to Induce Cyclin D1 During G2 Phase.” CellCycle, 1(1):50-58, 2002
ACADEMIC APPOINTMENTS:
Assistant Professor, Ocular Oncology
Department of Ophthalmology
University of Washington
Seattle, Washington
September 2016 - Present
MEDICAL TRAINING:
Ocular Oncology Fellowship, August 2015 – August 2016
Moorfields Eye Hospital and St. Bartholomew Hospital
London, England, United Kingdom
Ophthalmology Residency, July 2012 – June 2015
The University of Michigan Kellogg Eye Center
Ann Arbor, Michigan
Transitional Year Internship, July 2011 – June 2012
Riverside Methodist Hospital, OhioHealth
Columbus, Ohio
EDUCATION:
Doctor of Medicine, 2007- 2011.
The Ohio State University. Columbus, OH.
Master of Science, Statistics. 2005 – 2007
Brigham Young University. Provo, UT.
Thesis: “An Adaptive Bayesian Approach to Bernoulli Response Clinical Trials”
Bachelor of Science, Biostatistics. 2000-2005
Brigham Young University. Provo, UT.
SOCIETY MEMBERSHIP:
2012-Present American Academy of Ophthalmology
2012-Present Association for Research in Vision and Ophthalmology
2013-Present International Society of Ocular Oncology
2016-Present Washington Academy of Eye Physicians and Surgeons
PEER REVEIWED PUBLICATIONS:
1. Fabian ID, Stacey AW, Sagoo MS, Reddy MA. "Primary Enucleation for Group D Retinoblastoma in the Era of Systemic and Targeted Chemotherapy: The Price of Retaining an Eye." British Journal of Ophthalmology. In Press
2. Fabian ID, Thaung C, AlHarby L, Sisley K, Mudhar HS, Doherty RE, Stacey AW, Arora AK, Cohen VML, Sagoo MS. “Late Solitary Extraocular Recurrence from Previously Resected Iris Melanoma.” American Journal of Ophthalmology. In Press
3. Fabian ID, Naeem Z, Stacey AW, Chowdhery T, Duncan C, Reddy MA, Sagoo MS. “Long-term Visual Acuity, Strabismus, and Nystagmus Outcomes Following Multimodality Treatment in Group D Retinoblastoma Eyes.” American Journal of Ophthalmology. 179. July 2017, pp. 137-144
4. Stacey AW, Lavric A, Thaung C, Siddeq S, Sagoo MS. “Solitary Iris Plasmacytoma With Anterior Chamber Crystalline Deposits.” Cornea. 36(7). July 2017, pp: 875-877.
5. Fabian ID, Stacey AW, Chowdhury T, Duncan C, Karaa EK, Scheimberg I, Reddy MA Sagoo MS. "High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes." Ophthalmology. 124(6). June 2017, pp. 851-858
6. Fabian ID, Johnson KP, Stacey AW, Sagoo MS, Reddy MA. “Focal laser treatment in addition to chemotherapy for retinoblastoma.” Cochrane Database Systemic Reviews. June 2017.
7. Fabian ID, Stacey AW, Papastefanou V, Al Harby L, Arora AK, Sagoo MS, Cohen VML "Primary Photodynamic Therapy with Verteporfin for Small Pigmented Posterior Pole Choroidal Melanoma" Eye. 31(4). April 2017, pp. 519-528.
8. Fabian ID, Stacey AW, Johnson KC, Onadim Z, Chowdhury T, Duncan C, Reddy MA Sagoo MS. "Primary Intravenous Chemotherapy for Group D Retinoblastoma: A 13-Year Retrospective Analysis." British Journal of Ophthalmology. 101(1). January 2017, pp. 82-88.
9. Kondapalli SS, Czyz CM, Stacey AW, Cahill KV, Foster JA. "Use of Kaolin-impregnated Gauze for Improvement of Intraoperative Hemostasis and Postoperative Wound Healing in Blepharoplasty." Journal of Clinical Aesthetic Dermatology. 9(6). June 2016, pp. 51-55.
10. Kahana A, Gemmete JJ, Stacey AW. “Author Response: Periorbital Sclerotherapy Caution." Ophthalmic Plastic and Reconstructive Surgery. 32 (3). May-June 2016. 238-239
11. Stacey AW, Demirci H “Serial Intravitreal Bevacizumab Injections Slow the Progression of Radiation Maculopathy Following Iodine-125 Plaque Radiotherapy". The Open Ophthalmology Journal. 10. March 2016. 103-110.
12. Stacey AW, Borri M, De Francesco S, Antenore AS, Meniacacci F, Hadjistiliano T. “A Case of Anterior Chamber Cholesterolosis Due To Coats' Disease and A Review of Reported Cases.” The Open Ophthalmology Journal. 10. February 2016. 27-32
13. Wu CY, Stacey AW, Kahana A. “Simultaneous Versus Staged Balanced Decompression for Thyroid-Related Compressive Optice Neuropathy." Ophthalmic Plastic and Reconstructive Surgery. 32(6). Nov/Dec 2016. Pp. 462-467
14. Czyz CN, Bacon T, Stacey AW, Cahill EN, Costin BR. Karanfilov BI, Cahill KV. “Nasolacrimal system aeration on computed tomographic imaging: sex and age variation.” Ophthalmic Plastic and Reconstructive Surgery. 32(1). Jan-Feb 2016. 11-16.
15. Stacey AW, Gemmete JJ, Kahana A. “Management of Orbital and Periocular Vascular Anomalies: A Review.” Ophthalmic Plastic and Reconstructive Surgery. 31 (6). Nov-Dec 2015. pp: 427-436
16. Stacey AW, Sparagna C, Borri M, Rizzo S, Hadjistiliano T. “A 6-year-old boy with Cornealia de Lange Syndrome and Coats' Disease: case report and review of the literature.” Journal of the American Association for Pediatric Ophthalmology and Strabismus. 19 (5). October 2015. pp: 474-478.
17. Breker DA, Stacey AW, Srinivasan A, Bursztyn L, Trobe JD, Johnson MW. “Vision Loss Caused by Retinal and Lateral Geniculate Body Infarction in H1N1 Influenza.” Journal of Neuroophthalmology. 35 (3). September 2015. pp: 265-269.
18. Stacey AW, Czyz CN. “Author Response: Risk of Ocular Blood Splatter During Oculofacial Plastic Surgery.” Investigative Ophthalmology and Visual Science (IOVS). 31 (3). May-June 2015. pp: 248
19. Stacey AW, Czyz CN, Foster JA. “Risk of Ocular Blood Splatter During Oculofacial Plastic Surgery.” Ophthalmic Plastic and Reconstructive Surgery. 31(3). May-June 2015. pp: 182-186
20. Stacey AW, Sozener CB, Besirli CG. “Hypertensive Emergency Presenting as Blurry Vision in a Patient with Hypertensive Chorioretinopathy.” International Journal of Emergency Medicine. 8 (13). April 23, 2015.
21. Czyz CN, Bacon T, Stacey AW, Cahill EN, Costin BR. Karanfilov BI, Cahill KV. “Nasolacrimal system aeration on computed tomographic imaging: effects of patient positioning and scan orientation.” Clinical Ophthalmology. 11(9). March 2015. pp: 469-73.
22. Stacey AW, Czyz CN. “Author Response: An Analysis of the Use of Multiple Comparison Corrections in Ophthalmology Research.” Investigative Ophthalmology and Visual Science (IOVS). 53(9), 2012. pp:5955
23. Stacey AW, Pouly S, Czyz CN. “An Analysis of the Use of Multiple Comparison Corrections in Ophthalmology Research.” Investigative Ophthalmology and Visual Science (IOVS). 53(4), 2012. pp:1830-4
24. Hill RH, Shiels WE, Foster JA, Czyz CN, Stacey A, Everman DR, Cahill KV. “Percutaneous Drainage and Ablation as First Line Therapy for Macrocystic and Microcystic Orbital Lumphatic Malformations.” Ophthalmic Plastic and Reconstructive Surgery. 28(2), 2012. pp:119-25
25. Dolman PJ, Cahill K, Czyz CN, Douglas RS, Elner VM, Feldon S, Kazim M, Lucarelli M, Sivak-Collcott J, Stacey AW, Strianese D, Uddin J. “Reliability of estimating ductions in thyroid eye disease: an international thyroid eye disease society multicenter study.” Ophthalmology. 119(2), 2012. pp:382-9
26. Czyz CN, Kalwerisky K, Stacey AW, Foster JA, Hill RH, Everman KR, Cahill KV, DeMartelaere S. “Initial treatment of ocular exposure and associated complications in severe periorbital thermal injuries.” Journal of Trauma. 71(5), 2011. pp: 1455-9
27. Stacey A, Sheffield N, Crandall KA, “Calculating expected DNA remnants from ancient founding events in human population genetics.” BMC Genetics. 9:66, 2008.
28. Hitomi M, Yang K, Stacey AW, Stacey DW, “Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell cycle progression.” Molecular and Cellular Biology 28(17), 2008
29. Sa G, Hitomi M, Harwalkar J, Stacey AW, GC GC, Stacey DW, “Ras Is Active Throughout the Cell Cycle but Is Able to Induce Cyclin D1 During G2 Phase.” CellCycle, 1(1):50-58, 2002
